New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial
Abdulla A. Damluji(Inova Health System), Raul D. Mitrani(University of Miami), George R. Marzouka(University of Miami), James O. Coffey(Mount Sinai Medical Center), Robert J. Myerburg(University of Miami), Mohammed Salim Al‐Damluji(UConn Health), Mauricio G. Cohen(Santa Ana College), Juan F. Viles-González(University of Miami), Mauro Moscucci(Alaska Heart and Vascular Institute)
Cited by 11
Related Papers
Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association
|Circulation|2017|1.8k
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
|Journal of the American College of Cardiology|2021|1.5k
Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation
|Journal of the American College of Cardiology|2013|643
Sarcopenia and Cardiovascular Diseases
|Circulation|2023|563